Cover Image
市場調查報告書

EU5個國家的心血管監控·診斷設備市場未來展望

EU5 Cardiovascular Monitoring and Diagnostic Devices Market Outlook to 2020

出版商 GlobalData 商品編碼 301477
出版日期 內容資訊 英文 145 Pages
訂單完成後即時交付
價格
Back to Top
EU5個國家的心血管監控·診斷設備市場未來展望 EU5 Cardiovascular Monitoring and Diagnostic Devices Market Outlook to 2020
出版日期: 2014年05月05日 內容資訊: 英文 145 Pages
簡介

本報告提供歐洲的主要5個國家(法國·德國·義大利·西班牙·英國)的心血管監視·診斷用設備市場相關分析,提供整體市場規模(以金額·數量為準)的實際成果值·預測值,及市場價格趨勢,市場佔有率(各流通管道·各企業),各國市場的詳細趨勢,再加上主要企業的概要與策略,開發中的產品,最新的市場動靜(資本交易及其他)等調查,並將結果概述為以下內容。

第1章 目錄

第2章 簡介

  • 本報告概要
  • 心血管監控·診斷設備市場分類
  • 分析對象市場定義

第3章 EU5個國家的心血管監控·診斷設備市場

  • 市場收益額的整體趨勢(總計16年份)
  • 不同分類的市場收益額比較
  • 市場收益額的實際成果值(過去8年份)
  • 市場收益額的預測值(今後9年份)
  • 市場規模的整體趨勢(總計16年份)
  • 市場規模的實際成果值(過去8年份)
  • 市場規模的預測值(今後9年份)
  • 各企業的市場佔有率(以金額為準)

第4章 法國的心血管監控·診斷設備市場

  • 市場收益額的實際成果值(以金額為準,過去8年份)
  • 市場收益額的預測值(以金額為準,今後9年份)
  • 市場規模的實際成果值(以數量為準,過去8年份)
  • 市場規模的預測值(以數量為準,今後9年份)
  • 平均價格趨勢(總計16年份)
  • 各流通型態市場佔有率(以金額為準)
  • 各企業的市場佔有率(以金額為準)

第5章 德國的心血管監控·診斷設備市場

第6章 義大利的心血管監控·診斷設備市場

第7章 西班牙的心血管監控·診斷設備市場

第8章 英國的心血管監控·診斷設備市場

第9章 主要企業概要

  • GE Healthcare
  • Philips Healthcare
  • Schiller AG
  • Mortara Instrument, Inc.
  • OSI Systems, Inc.
  • Welch Allyn Inc.
  • 福田電子
  • Opto Circuits India Limited
  • CareFusion Corporation
  • 日本光電工業

第10章 開發中產品

第11章 近幾年的市場趨勢

  • 企業通訊(全3件)
  • 財務相關資訊(全16件)
  • 政府·公益相關資訊(1件)
  • 其他重要的動向(全3件)
  • 產品資訊(全2件)
  • 研究開發(R&D)資訊(1件)
  • 策略·產業計畫相關資訊(1件)

第12章 附錄

圖表一覽

目錄
Product Code: GDMECR0101DB

GlobalData's new report, "EU5 Cardiovascular Monitoring and Diagnostic Devices Market Outlook to 2020", provides key market data on the EU5 Cardiovascular Monitoring and Diagnostic Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems, Event Monitoring Systems and Holter Monitoring Systems.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiovascular Monitoring and Diagnostic Devices market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Cardiovascular Monitoring and Diagnostic Devices categories - Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems, Event Monitoring Systems and Holter Monitoring Systems.
  • Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
  • 2012 company shares and distribution shares data for the market category.
  • Global corporate-level profiles of key companies operating within the EU5 Cardiovascular Monitoring and Diagnostic Devices market.
  • Key players covered include GE Healthcare, Philips Healthcare, Welch Allyn Inc., OSI Systems, Inc., CareFusion Corporation, Cardiac Science Corporation, Schiller AG and Card Guard Scientific Survival, Ltd.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Cardiovascular Monitoring and Diagnostic Devices Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Cardiovascular Monitoring and Diagnostic Devices Market, EU5

  • 3.1. Cardiovascular Monitoring and Diagnostic Devices Market, EU5, Revenue ($m), 2005-2020
  • 3.2. Cardiovascular Monitoring and Diagnostic Devices Market, EU5, Category Comparison by Revenue ($m), 2005-2020
  • 3.3. Cardiovascular Monitoring and Diagnostic Devices Market, EU5, Revenue ($m), 2005-2012
  • 3.4. Cardiovascular Monitoring and Diagnostic Devices Market, EU5, Revenue ($m), 2012-2020
  • 3.5. Cardiovascular Monitoring and Diagnostic Devices Market, EU5, Volume (Units), 2005-2020
  • 3.6. Cardiovascular Monitoring and Diagnostic Devices Market, EU5, Volume (Units), 2005-2012
  • 3.7. Cardiovascular Monitoring and Diagnostic Devices Market, EU5, Volume (Units), 2012-2020
  • 3.8. Cardiovascular Monitoring and Diagnostic Devices Market, EU5, Company Share by Revenue ($m), 2011-2012

4. Cardiovascular Monitoring and Diagnostic Devices Market, France

  • 4.1. Cardiovascular Monitoring and Diagnostic Devices Market, France, Revenue ($m), 2005-2012
  • 4.2. Cardiovascular Monitoring and Diagnostic Devices Market, France, Revenue ($m), 2012-2020
  • 4.3. Cardiovascular Monitoring and Diagnostic Devices Market, France, Volume (Units), 2005-2012
  • 4.4. Cardiovascular Monitoring and Diagnostic Devices Market, France, Volume (Units), 2012-2020
  • 4.5. Cardiovascular Monitoring and Diagnostic Devices Market, France, Average Price ($), 2005-2020
  • 4.6. Cardiovascular Monitoring and Diagnostic Devices Market, France, Distribution Share by Revenue ($m), 2011-2012
  • 4.7. Cardiovascular Monitoring and Diagnostic Devices Market, France, Company Share by Revenue ($m), 2011-2012

5. Cardiovascular Monitoring and Diagnostic Devices Market, Germany

  • 5.1. Cardiovascular Monitoring and Diagnostic Devices Market, Germany, Revenue ($m), 2005-2012
  • 5.2. Cardiovascular Monitoring and Diagnostic Devices Market, Germany, Revenue ($m), 2012-2020
  • 5.3. Cardiovascular Monitoring and Diagnostic Devices Market, Germany, Volume (Units), 2005-2012
  • 5.4. Cardiovascular Monitoring and Diagnostic Devices Market, Germany, Volume (Units), 2012-2020
  • 5.5. Cardiovascular Monitoring and Diagnostic Devices Market, Germany, Average Price ($), 2005-2020
  • 5.6. Cardiovascular Monitoring and Diagnostic Devices Market, Germany, Distribution Share by Revenue ($m), 2011-2012
  • 5.7. Cardiovascular Monitoring and Diagnostic Devices Market, Germany, Company Share by Revenue ($m), 2011-2012

6. Cardiovascular Monitoring and Diagnostic Devices Market, Italy

  • 6.1. Cardiovascular Monitoring and Diagnostic Devices Market, Italy, Revenue ($m), 2005-2012
  • 6.2. Cardiovascular Monitoring and Diagnostic Devices Market, Italy, Revenue ($m), 2012-2020
  • 6.3. Cardiovascular Monitoring and Diagnostic Devices Market, Italy, Volume (Units), 2005-2012
  • 6.4. Cardiovascular Monitoring and Diagnostic Devices Market, Italy, Volume (Units), 2012-2020
  • 6.5. Cardiovascular Monitoring and Diagnostic Devices Market, Italy, Average Price ($), 2005-2020
  • 6.6. Cardiovascular Monitoring and Diagnostic Devices Market, Italy, Distribution Share by Revenue ($m), 2011-2012
  • 6.7. Cardiovascular Monitoring and Diagnostic Devices Market, Italy, Company Share by Revenue ($m), 2011-2012

7. Cardiovascular Monitoring and Diagnostic Devices Market, Spain

  • 7.1. Cardiovascular Monitoring and Diagnostic Devices Market, Spain, Revenue ($m), 2005-2012
  • 7.2. Cardiovascular Monitoring and Diagnostic Devices Market, Spain, Revenue ($m), 2012-2020
  • 7.3. Cardiovascular Monitoring and Diagnostic Devices Market, Spain, Volume (Units), 2005-2012
  • 7.4. Cardiovascular Monitoring and Diagnostic Devices Market, Spain, Volume (Units), 2012-2020
  • 7.5. Cardiovascular Monitoring and Diagnostic Devices Market, Spain, Average Price ($), 2005-2020
  • 7.6. Cardiovascular Monitoring and Diagnostic Devices Market, Spain, Distribution Share by Revenue ($m), 2011-2012
  • 7.7. Cardiovascular Monitoring and Diagnostic Devices Market, Spain, Company Share by Revenue ($m), 2011-2012

8. Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom

  • 8.1. Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Revenue ($m), 2005-2012
  • 8.2. Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Revenue ($m), 2012-2020
  • 8.3. Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Volume (Units), 2005-2012
  • 8.4. Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Volume (Units), 2012-2020
  • 8.5. Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Average Price ($), 2005-2020
  • 8.6. Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Distribution Share by Revenue ($m), 2011-2012
  • 8.7. Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Company Share by Revenue ($m), 2011-2012

9. Overview of Key Companies in EU5 Cardiovascular Monitoring and Diagnostic Devices Market

  • 9.1. GE Healthcare
    • 9.1.1. Company Overview
  • 9.2. Philips Healthcare
    • 9.2.1. Company Overview
  • 9.3. Schiller AG
    • 9.3.1. Company Overview
  • 9.4. Mortara Instrument, Inc.
    • 9.4.1. Company Overview
  • 9.5. OSI Systems, Inc.
    • 9.5.1. Company Overview
  • 9.6. Welch Allyn Inc.
    • 9.6.1. Company Overview
  • 9.7. Fukuda Denshi Co., Ltd.
    • 9.7.1. Company Overview
  • 9.8. Opto Circuits India Limited
    • 9.8.1. Company Overview
  • 9.9. CareFusion Corporation
    • 9.9.1. Company Overview
  • 9.10. Nihon Kohden Corporation
    • 9.10.1. Company Overview

10. Cardiovascular Monitoring and Diagnostic Devices Market Pipeline Products

11. Recent Developments

  • 11.1. Corporate Communications
    • 11.1.1. Apr 11, 2014: Deltex Medical Announces Board Changes
    • 11.1.2. Feb 04, 2014: BioLight Announces that its Subsidiary Micromedic Reports Success with CellDetect for Detecting Cervical Cancer in a Pilot Study at a Central Hospital in Beijing, Receives Order for 100,000 Detection Kits
    • 11.1.3. Feb 04, 2014: Nicox appoints Evelyne Nguyen as CFO
  • 11.2. Financial Announcements
    • 11.2.1. Apr 16, 2014: Osteoarthritis Study shows ActiPatch Therapy Significantly Relieves Knee Pain
    • 11.2.2. Apr 02, 2014: Nicox 2013 financial results and business update
    • 11.2.3. Mar 11, 2014: Deltex Medical Group Announces Results Summary for the year ended 31 December 2013
    • 11.2.4. Jan 22, 2014: XIGDUO (dapagliflozin and metformin hydrochloride) approved in the European Union for type 2 diabetes
    • 11.2.5. Nov 14, 2013: Announcement of financial statements 2012/13
    • 11.2.6. Aug 20, 2013: Ambu Reports Q3 Fiscal 2013 Results
    • 11.2.7. Aug 20, 2013: LifeWatch with again clearly improved results for Q2 2013
    • 11.2.8. Jul 31, 2013: Nicox First Half 2013 Financial Results and Business Update
    • 11.2.9. Jul 29, 2013: Mednax Acquires Neonatology Practice In Texas
    • 11.2.10. Jun 28, 2013: Novartis Europharm Receives CHMP Positive Opinion For Exforge HCT
    • 11.2.11. Jun 28, 2013: Breckenridge Announces Paragraph IV ANDA Litigation with Par Pharmaceutical & Alkermes Pharma Ireland Limited for its ANDA Megestrol Acetate Oral Suspension
    • 11.2.12. Jun 27, 2013: GlaxoSmithKline Trading Services Receives CHMP Positive Opinion For Tafinlar
    • 11.2.13. May 21, 2013: Novartis's Ranibizumab Receives NICE Recommendation For Treatment Of Macular Edema
    • 11.2.14. May 15, 2013: NicOx Reports Q1 2013 Results
    • 11.2.15. May 13, 2013: LifeWatch AG Reports First Quarter 2013 Results
    • 11.2.16. May 02, 2013: Interim report for Q2 2012/13 and for the half-year period 1 October 2012 to 31 March 2013
  • 11.3. Government and Public Interest
    • 11.3.1. Oct 23, 2013: Additional dedicated trainer hospital established in the USA
  • 11.4. Other Significant Developments
    • 11.4.1. Mar 26, 2014: Deltex Medical Group Extends NHS Supply Chain Update
    • 11.4.2. Jan 06, 2014: Nicox provides a summary of its progress in 2013
    • 11.4.3. Nov 15, 2013: Millar Appointed Exclusive US Distributor of CD Leycom INCA Pressure-Volume Loop System
  • 11.5. Product News
    • 11.5.1. Apr 02, 2014: Deltex Medical Group provides NHS England implementation plan update
    • 11.5.2. Oct 07, 2013: MDxHealth's Prostate Cancer Test Meets Endpoints In DOCUMENT Trial
  • 11.6. Research And Development
    • 11.6.1. Jun 04, 2013: Immunicum's Intuvax Is Registered As Brand In EU At Office for Harmonization in the Internal Market
  • 11.7. Strategy And Business Planning
    • 11.7.1. Jul 02, 2013: Apogenix Strengthens Patent Position for Apocept In Europe And Canada

12. Appendix

  • 12.1. Research Methodology
    • 12.1.1. Coverage
    • 12.1.2. Secondary Research
    • 12.1.3. Primary Research
    • 12.1.4. Market Modeling and Forecasting
    • 12.1.5. Company Share Analysis
    • 12.1.6. Distribution Share Analysis
  • 12.2. Expert Panel
  • 12.3. GlobalData Consulting
  • 12.4. Contact Us
  • 12.5. Disclaimer

List of Tables

  • Table 1: Cardiovascular Monitoring and Diagnostic Devices Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2005-2020
  • Table 2: Cardiovascular Monitoring and Diagnostic Devices Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2005-2020
  • Table 3: Cardiovascular Monitoring and Diagnostic Devices Market, EU5, Revenue ($m), Historic, USD Constant, 2005-2012
  • Table 4: Cardiovascular Monitoring and Diagnostic Devices Market, EU5, Revenue ($m), Forecast, USD Constant, 2012-2020
  • Table 5: Cardiovascular Monitoring and Diagnostic Devices Market, EU5, Volume (Units), 2005-2020
  • Table 6: Cardiovascular Monitoring and Diagnostic Devices Market, EU5, Volume (Units), Historic, 2005-2012
  • Table 7: Cardiovascular Monitoring and Diagnostic Devices Market, EU5, Volume (Units), Forecast, 2012-2020
  • Table 8: Cardiovascular Monitoring and Diagnostic Devices Market, EU5, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 9: Cardiovascular Monitoring and Diagnostic Devices Market, France, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 10: Cardiovascular Monitoring and Diagnostic Devices Market, France, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 11: Cardiovascular Monitoring and Diagnostic Devices Market, France, Volume (Units), Historic, 2005-2012
  • Table 12: Cardiovascular Monitoring and Diagnostic Devices Market, France, Volume (Units), Forecast, 2012-2020
  • Table 13: Cardiovascular Monitoring and Diagnostic Devices Market, France, Average Price ($), Historic, 2005-2012
  • Table 14: Cardiovascular Monitoring and Diagnostic Devices Market, France, Average Price ($), Forecast, 2012-2020
  • Table 15: Cardiovascular Monitoring and Diagnostic Devices Market, France, Distribution Share by Revenue ($m), USD Constant, 2011-2012
  • Table 16: Cardiovascular Monitoring and Diagnostic Devices Market, France, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 17: Cardiovascular Monitoring and Diagnostic Devices Market, Germany, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 18: Cardiovascular Monitoring and Diagnostic Devices Market, Germany, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 19: Cardiovascular Monitoring and Diagnostic Devices Market, Germany, Volume (Units), Historic, 2005-2012
  • Table 20: Cardiovascular Monitoring and Diagnostic Devices Market, Germany, Volume (Units), Forecast, 2012-2020
  • Table 21: Cardiovascular Monitoring and Diagnostic Devices Market, Germany, Average Price ($), Historic, 2005-2012
  • Table 22: Cardiovascular Monitoring and Diagnostic Devices Market, Germany, Average Price ($), Forecast, 2012-2020
  • Table 23: Cardiovascular Monitoring and Diagnostic Devices Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2011-2012
  • Table 24: Cardiovascular Monitoring and Diagnostic Devices Market, Germany, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 25: Cardiovascular Monitoring and Diagnostic Devices Market, Italy, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 26: Cardiovascular Monitoring and Diagnostic Devices Market, Italy, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 27: Cardiovascular Monitoring and Diagnostic Devices Market, Italy, Volume (Units), Historic, 2005-2012
  • Table 28: Cardiovascular Monitoring and Diagnostic Devices Market, Italy, Volume (Units), Forecast, 2012-2020
  • Table 29: Cardiovascular Monitoring and Diagnostic Devices Market, Italy, Average Price ($), Historic, 2005-2012
  • Table 30: Cardiovascular Monitoring and Diagnostic Devices Market, Italy, Average Price ($), Forecast, 2012-2020
  • Table 31: Cardiovascular Monitoring and Diagnostic Devices Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2011-2012
  • Table 32: Cardiovascular Monitoring and Diagnostic Devices Market, Italy, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 33: Cardiovascular Monitoring and Diagnostic Devices Market, Spain, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 34: Cardiovascular Monitoring and Diagnostic Devices Market, Spain, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 35: Cardiovascular Monitoring and Diagnostic Devices Market, Spain, Volume (Units), Historic, 2005-2012
  • Table 36: Cardiovascular Monitoring and Diagnostic Devices Market, Spain, Volume (Units), Forecast, 2012-2020
  • Table 37: Cardiovascular Monitoring and Diagnostic Devices Market, Spain, Average Price ($), Historic, 2005-2012
  • Table 38: Cardiovascular Monitoring and Diagnostic Devices Market, Spain, Average Price ($), Forecast, 2012-2020
  • Table 39: Cardiovascular Monitoring and Diagnostic Devices Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2011-2012
  • Table 40: Cardiovascular Monitoring and Diagnostic Devices Market, Spain, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 41: Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 42: Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 43: Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Volume (Units), Historic, 2005-2012
  • Table 44: Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Volume (Units), Forecast, 2012-2020
  • Table 45: Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Average Price ($), Historic, 2005-2012
  • Table 46: Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Average Price ($), Forecast, 2012-2020
  • Table 47: Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2011-2012
  • Table 48: Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 49: Cardiovascular Monitoring and Diagnostic Devices Market Pipeline Products
  • Table 50: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country

List of Figures

  • Figure 1: Cardiovascular Monitoring and Diagnostic Devices Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2005-2020
  • Figure 2: Cardiovascular Monitoring and Diagnostic Devices Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2005-2020
  • Figure 3: Cardiovascular Monitoring and Diagnostic Devices Market, EU5, Revenue ($m), Historic, USD Constant, 2005-2012
  • Figure 4: Cardiovascular Monitoring and Diagnostic Devices Market, EU5, Revenue ($m), Forecast, USD Constant, 2012-2020
  • Figure 5: Cardiovascular Monitoring and Diagnostic Devices Market, EU5, Volume (Units), 2005-2020
  • Figure 6: Cardiovascular Monitoring and Diagnostic Devices Market, EU5, Volume (Units), Historic, 2005-2012
  • Figure 7: Cardiovascular Monitoring and Diagnostic Devices Market, EU5, Volume (Units), Forecast, 2012-2020
  • Figure 8: Cardiovascular Monitoring and Diagnostic Devices Market, EU5, Company Share (%), 2012
  • Figure 9: Cardiovascular Monitoring and Diagnostic Devices Market, France, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 10: Cardiovascular Monitoring and Diagnostic Devices Market, France, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 11: Cardiovascular Monitoring and Diagnostic Devices Market, France, Volume (Units), Historic, 2005-2012
  • Figure 12: Cardiovascular Monitoring and Diagnostic Devices Market, France, Volume (Units), Forecast, 2012-2020
  • Figure 13: Cardiovascular Monitoring and Diagnostic Devices Market, France, Company Share (%), 2012
  • Figure 14: Cardiovascular Monitoring and Diagnostic Devices Market, Germany, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 15: Cardiovascular Monitoring and Diagnostic Devices Market, Germany, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 16: Cardiovascular Monitoring and Diagnostic Devices Market, Germany, Volume (Units), Historic, 2005-2012
  • Figure 17: Cardiovascular Monitoring and Diagnostic Devices Market, Germany, Volume (Units), Forecast, 2012-2020
  • Figure 18: Cardiovascular Monitoring and Diagnostic Devices Market, Germany, Company Share (%) 2012
  • Figure 19: Cardiovascular Monitoring and Diagnostic Devices Market, Italy, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 20: Cardiovascular Monitoring and Diagnostic Devices Market, Italy, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 21: Cardiovascular Monitoring and Diagnostic Devices Market, Italy, Volume (Units), Historic, 2005-2012
  • Figure 22: Cardiovascular Monitoring and Diagnostic Devices Market, Italy, Volume (Units), Forecast, 2012-2020
  • Figure 23: Cardiovascular Monitoring and Diagnostic Devices Market, Italy, Company Share (%), 2012
  • Figure 24: Cardiovascular Monitoring and Diagnostic Devices Market, Spain, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 25: Cardiovascular Monitoring and Diagnostic Devices Market, Spain, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 26: Cardiovascular Monitoring and Diagnostic Devices Market, Spain, Volume (Units), Historic, 2005-2012
  • Figure 27: Cardiovascular Monitoring and Diagnostic Devices Market, Spain, Volume (Units), Forecast, 2012-2020
  • Figure 28: Cardiovascular Monitoring and Diagnostic Devices Market, Spain, Company Share (%), 2012
  • Figure 29: Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 30: Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 31: Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Volume (Units), Historic, 2005-2012
  • Figure 32: Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Volume (Units), Forecast, 2012-2020
  • Figure 33: Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Company Share (%), 2012
  • Figure 34: GlobalData Epidemiology-Based Forecasting Model
  • Figure 35: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 36: Primary Interviews by Participant Type (%)
Back to Top